Wordt geladen...
Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design
With the event of new Molecular targets, clinical trial design requirements to perform these trials are changing. This paper discusses some of the considerations that need to be taken into account when designing a trial, including those trials that assess combinations of targets.
Bewaard in:
| Gepubliceerd in: | Mol Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528372/ https://ncbi.nlm.nih.gov/pubmed/22386481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2012.01.009 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|